Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial.
- Resource Type
- Article
- Source
- ESC Heart Failure; Jun2020, Vol. 7 Issue 3, p856-864, 9p
- Subject
ANGIOTENSIN receptors NEPRILYSIN HEART failure - Language
- ISSN
- 20555822